NFE2L2 and Insulin resistance: Scopoletin at 10 and 30 mg/Kg (oral route) protected rats against methylglyoxal-induced hyperglycemia and insulin resistance via Akt phosphorylation and upregulation of Nrf2 and PPARγ signaling pathways [132].